Vital Signsby BridgeheadAll voices

01  Voice · Academic · Rare diseases

Wonyul Lee: no licensed photograph is held, so the academic plate is shown instead.
Academic

Wonyul Lee

Ph.D., senior statistical reviewer at CDER

Press citations per month · linked articles
1
0
0
0
0
0
0
0
Apr 2026MayJuneJulyAugSeptOctNovto date
1

press citation on 1 topic since 17 Apr 2026 · last quoted 17 Apr 2026

02  Quoted on · 1 of 29 topics

Open the topic

Wonyul Lee: key facts

Kind of voice
Academic
Role
Ph.D., senior statistical reviewer at CDER
Quoted on
Rare diseases
Tracked press citations
1
Most recently quoted
17 Apr 2026

04  The signal · where Wonyul Lee sits on rare diseases

Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
  2. 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
  3. 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
  4. 25=Kelley KidwellAcademicPh.D., University of Michigan biostatistician1
  5. 25=Susana ZaphAcademicPh.D., U.S. head of QSP at Sanofi1
  6. 25=Wonyul LeeAcademicPh.D., senior statistical reviewer at CDER1
  7. 25=Dr Whitney ThompsonAcademicScientist at Mayo Clinic1
  8. 25=Laura LambertAcademicScientist at Mayo Clinic1

Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →

05  On the record · press

What Wonyul Lee has said

By outlet · linked articles
  • fiercebiotech.com1

Where Wonyul Lee has been quoted

  1. 01Small pools, big ideas: How the rare disease community is reimagining clinical trialsfiercebiotech.com · 17 Apr 2026

Verbatim

“it is critical to ensure that the treatment and control groups are as similar as possible in many aspects”
Ph.D., senior statistical reviewer at CDER · Rare diseases · fiercebiotech.com · 17 Apr 2026 · Read the article

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.